Inactive Instrument

News Sartorius Aktiengesellschaft Other OTC

Equities

Sartorius Partners With Sanofi for Biomanufacturing Platform	05-13	MT
Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification	05-13	EQ
SARTORIUS : Target cut by -6.1%	04-30
SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg	04-24	ZD
SARTORIUS VORZUEGE : DZ Bank gives a Sell rating	04-23	ZD
US competitor Danaher boosts Merck KGaA and Sartorius	04-23	DP
SARTORIUS VORZUEGE : Barclays remains Neutral	04-23	ZD
SARTORIUS VORZUEGE : Deutsche Bank remains Neutral	04-22	ZD
JPMorgan lowers target for Sartorius to 340 euros - 'Overweight'	04-22	DP
SARTORIUS : Q1 24: Top-line miss but a few positives	04-22
SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating	04-22	ZD
SARTORIUS VORZUEGE : Deutsche Bank reaffirms its Neutral rating	04-19	ZD
German Shares Close Green as Bundesbank Sees Q1 Economic Growth	04-18	MT
SARTORIUS VORZUEGE : Barclays remains Neutral	04-18	ZD
FTSE 100 up despite hawkish Fed rates outlook	04-18	AN
Sartorius continues recovery after weak start - share price slide	04-18	DP
SARTORIUS VORZUEGE : Warburg Research reiterates its Neutral rating	04-18	ZD
Sartorius : Conference Call Q1\|2024 Presentation	04-18	PU
Sartorius Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	04-18	CI
Sartorius and subsidiary Stedim under pressure after weak figures	04-18	DP

No results for this search

SARTORIUS : Target cut by -6.1%

April 30, 2024 at 12:35 pm